CDEK
← All trials

NCT07151378

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date
Sep 16, 2025
Primary completion
Sep 22, 2030
Completion date
Sep 22, 2030
First posted
Sep 3, 2025
Last posted
Sep 3, 2025
Enrollment
150
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.